Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Tamara Ghanem

- PMLiVE

Genentech forges $800m autoimmune alliance with Parvus

Big vote of confidence in novel platform

- PMLiVE

After discount row, NICE finally says yes to first line Revlimid

England catches up with rest of Europe

- PMLiVE

Transitions in healthcare

By Dr Jonathan Reston

Lighthouse Medical Communications US continues its expansion with two new hires to its client services team

Anita Dudek joins Lighthouse’s client services team as an Account Director. Prior to joining Lighthouse, Anita led brand teams across oncology, respiratory, cardiovascular and diabetes therapeutic areas, as well as...

Lucid Group Communications Limited

- PMLiVE

Babylon expansion sparks ‘NHS destruction’ warnings

Necessary tech 'disruption' or cherrypicking?

- PMLiVE

Iovance up on good ASCO abstract data for cervical cancer therapy

Shares leap almost 20% after abstracts released

- PMLiVE

Venclexta plus Gazyva approval adds to non-chemo options in CLL

Joins Imbruvica combo in front line use

- PMLiVE

One hit, one miss as FDA panel votes on Daiichi’s cancer drugs

Setback for AML candidate quizartinib

- PMLiVE

Evolving behaviour change

By Paul Tanner

- PMLiVE

It’s not the end of the world, is it?

Industry change isn’t always gradual – it can be apocalyptic

- PMLiVE

Merck claims key FDA okay for Bavencio in kidney cancer

Will help boost underwhelming revenues

- PMLiVE

Myovant’s fibroids drug clears phase 3 trial, but shares sink

Investors concerned on how it stacks up against AbbVie rival

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links